Skip to main content

Inside the Market Thursday’s Insider Report: Three stocks that CEOs and board members are buying

Featured below are companies that have experienced recent insider trading activity in the public market through their direct and indirect ownerships, including accounts they have control or direction over.

The list features insider transaction activity; it does not convey total ownership information as an insider may hold numerous accounts.

Keep in mind, when looking at transaction activities by insiders, purchasing activity may reflect perceived value in a security. Selling activity may or may not be related to a stock’s valuation; perhaps an insider needs to raise money for personal reasons. An insider’s total holdings should be considered because a sale may, in context, be insignificant if this person has a large remaining position in the company. I tend to put great weight on insider transaction activity when I see multiple insiders trading a company’s shares or units.

Story continues below advertisement

Listed below are three stocks that have had recent insider buying activity.

Cantex Mine Development Corp. (CD-X)

This microcap stock has delivered astounding year-to-date returns, rallying over 300 per cent to close at $3.49 on April 10, up from 80 cents on Dec. 31, 2018.

On March 29, the chairman Chuck Fipke purchased 1.7-million shares at a price per share of $1 for an account in which he has indirect ownership (Charles E. Fipke Alter Ego Trust), initiating a portfolio position. Days prior, on March 22, he acquired 4.5-million shares at a cost per share of $1 for an account in which he has indirect ownership (0974052 B.C. Ltd.), lifting the account’s holdings to 15,553,137 shares.

Empire Company Ltd. (EMP.A-T)

On April 2, chair James Dickson acquired 2,150 shares at a price per share of $29.2727 for an account in which he has control or direction over (SJD Management Ltd.), increasing his account’s holdings to 15,500 shares. The cost of this investment was approximately $63,000.

Last month, we reported trades by two insiders that both took place on March 18. President and chief executive officer Michael Medline bought 10,600 shares at a cost per share of $28.2788, taking his portfolio’s position up to 40,600 shares. The cost of this investment was approximately $300,000.

Story continues below advertisement

In addition, the company’s chief financial officer Michael Vels invested just over $84,000 in shares of the company. He purchased 3,000 shares at a cost per share of $28.20, increasing his account’s holdings to 35,000 shares.

Tourmaline Oil Corp. (TOU-T)

Between April 29 and April 1, president and chief executive officer Mike Rose invested nearly $160,000 in shares of the company. He purchased a total of 7,730 shares across two accounts at an average price per share of approximately $20.62.

**

Listed below is a stock that has had recent selling activity reported by insiders.

Pason Systems Inc. (PSI-T)

Story continues below advertisement

Between March 20 and March 29, chair of the board and the company’s former president and chief executive officer James Hill sold a total of 325,100 shares at an average price per share of approximately $20.05 for an account in which he has indirect ownership (J.D.Hill Investments), leaving 8,991,480 shares in the account. Proceeds from these sales totaled over $6.5-million.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter